Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,903.50 -9.50 (-0.50%)

Bid:

1,904.00

Ask:

1,905.00

Spread: 1.00 (0.053%)

Market Cap: £76.34b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

GSK's Blenrep combinations accepted for review by US FDA

(Alliance News) - GSK PLC said on Monday that the US Food & Drug Administration accepted a biologics license application for its Blenrep combinations ...

GSK's Blenrep treatment accepted for review by FDA

(Sharecast News) - Pharma titan GSK has announced that US regulators have accepted for review Blenrep combinations for the treatment of relapsed or re...

TOP NEWS: GSK's Arexvy RSV vaccine approved in Japan for adults 50-59

(Alliance News) - GSK PLC said on Friday that Japan's Ministry of Health, Labour & Welfare has approved the expansion of its Arexvy respiratory syncy...

LONDON BRIEFING: GSK approval; Games Workshop trades ahead of forecast

(Alliance News) - London's FTSE 100 is called to open higher on Friday, while the pound and euro struggled ahead of a series key purchasing managers' ...

GSK's Arexvy approved for wider age range in Japan

(Sharecast News) - Biopharma giant GSK has announced that Japanese regulators have expanded the approved use of its Arexvy vaccine for severe respirat...

GSK hails positive results for linerixibat in treating relentless itch

(Alliance News) - GSK PLC on Tuesday said that its investigational targeted inhibitor linerixibat demonstrated sound results for a treatment of relent...

GSK's linerixibat meets primary endpoint

(Sharecast News) - Drugmaker GSK said on Tuesday that its linerixibat candidate had shown "positive" Phase III results in cholestatic pruritus in prim...

LONDON BROKER RATINGS: HSBC says 'buy' recruiters SThree and Hays

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and Friday: